Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Assets Average of $741.9 million for Q1 2026, down 24.6% year-over-year from $984.0 million in Q1 2025, and down 8.39% quarter-over-quarter from $809.9 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $741.9 million for Q1 2026.
- In Q1 2026, Assets Average fell 24.6% year-over-year to $741.9 million; the TTM figure through Mar 2026 stood at $741.9 million (down 24.6% YoY), while the FY2025 annual figure was $889.4 million, down 28.72% from the prior year.
- Assets Average for Q1 2026 stood at $741.9 million, down from $809.9 million in the prior quarter.
- The five-year high for Assets Average was $2.3 billion in Q1 2023, with the low at $741.9 million in Q1 2026.
- The 5-year median for Assets Average is $1.5 billion (2024), against an average of $1.6 billion.
- The sharpest annual moves came in 2022 and 2024: Assets Average soared 51.06% in 2022, then sank 39.94% in 2024.
- Maravai Lifesciences Holdings' Assets Average stood at $2.3 billion in 2022, then declined by 17.13% to $1.9 billion in 2023, then plunged by 39.11% to $1.1 billion in 2024, then fell by 29.16% to $809.9 million in 2025, then slipped by 8.39% to $741.9 million in 2026.
- Business Quant data shows MRVI's Assets Average at $741.9 million in Q1 2026, $809.9 million in Q4 2025, and $873.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 658.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 658.48 Mn |
| Mar 31, 2026 | 741.90 Mn |
| Dec 31, 2025 | 809.88 Mn |
| Sep 30, 2025 | 873.08 Mn |
| Jun 30, 2025 | 928.36 Mn |
| Mar 31, 2025 | 984.00 Mn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 1.36 Bn |
| Jun 30, 2024 | 1.44 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.88 Bn |
| Sep 30, 2023 | 2.27 Bn |
| Jun 30, 2023 | 2.29 Bn |
| Mar 31, 2023 | 2.30 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.21 Bn |
| Jun 30, 2022 | 2.11 Bn |
| Mar 31, 2022 | 1.98 Bn |
| Dec 31, 2021 | 1.91 Bn |
| Sep 30, 2021 | 1.75 Bn |